Precision Synthesized
for Innovation.

GLP-1 receptor agonist studied for glucose regulation and appetite modulation.

Dual GIP/GLP-1 receptor agonist for advanced metabolic research.

Triple receptor agonist (GLP-1 / GIP / glucagon) for next-gen metabolic studies.

Small-molecule NNMT inhibitor researched for adipocyte metabolism.

Selective growth hormone secretagogue for GH-pathway research.

Stabilized GHRH analog studied for body composition research.

Pre-blended Tesamorelin + Ipamorelin research stack.

Long Arg3 IGF-1 analog with extended half-life for cellular growth research.

Pentadecapeptide studied for tissue repair and gastrointestinal research.

Pre-blended BPC-157 + TB-500 research stack.

Synthetic thymosin beta-4 fragment for tissue repair research.

Nicotinamide adenine dinucleotide for cellular energy research.

Mitochondrial-derived peptide studied for metabolic and cellular health.

Tripeptide fragment of α-MSH studied for inflammation research.

Blended research peptide formulation for recovery studies.

Heptapeptide ACTH analog studied for neuroprotection and cognition.

Synthetic heptapeptide studied for anxiolytic and nootropic activity.

Research peptide studied for cognitive enhancement and neuroplasticity.

Delta sleep-inducing peptide studied for sleep architecture research.

Copper-binding tripeptide studied for skin and tissue regeneration.

Research blend studied for skin radiance and rejuvenation.

α-MSH analog studied for melanogenesis research.

Cyclic α-MSH analog studied for melanogenesis and appetite research.

Master antioxidant tripeptide studied for cellular detoxification and skin research.

Indoleamine hormone studied for circadian rhythm and antioxidant research.

Sterile water with 0.9% benzyl alcohol for peptide reconstitution.